Skip to main content
Top
Published in: BMC Health Services Research 1/2008

Open Access 01-12-2008 | Research article

Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study

Authors: Christa Meisinger, Margit Heier, Rüdiger Landgraf, Michael Happich, H-Erich Wichmann, Wolfgang Piehlmeier

Published in: BMC Health Services Research | Issue 1/2008

Login to get access

Abstract

Background

Epidemiological studies have shown that microalbuminuria is an important risk factor for arteriosclerosis, coronary heart disease and other vascular diseases in persons with type 2 diabetes. In the present study we examined the prevalence and risk factors for micro- and macroalbuminuria and examined glycemic control as well as treatment of modifiable cardiovascular risk factors in persons with known type 2 diabetes in Germany.

Methods

The presented data were derived from the 'KORA Augsburg Diabetes Family Study', conducted between October 2001 and September 2002. Participants were adults aged 29 years and older with previously diagnosed type 2 diabetes (n = 581). Microalbuminuria was defined as an albumin-creatinine ratio of 30 to 300 mg/g, and macroalbuminuria as an albumin-creatinine ratio of more than 300 mg/g.

Results

Microalbuminuria was revealed in 27.2% and macroalbuminuria in 9.0% of the 581 included diabetic persons. Multivariable regression analysis identified HBA1c, duration of diabetes, systolic blood pressure, serum creatinine, smoking and waist circumference as independent risk factors associated with albuminuria (micro- or macroalbuminuria). Relatively few persons with type 2 diabetes achieved treatment targets of HbA1c < 7% (46.6%), total cholesterol < 200 mg/dl (44.1%), and LDL cholesterol < 100 mg/dl (16.0%). Optimal HDL cholesterol values (> 45 mg/dl in men, > 55 mg/dl in women) were found in 55.8%, and blood pressure values < 130 and < 85 mmHg in 31.3% of the persons

Conclusion

Albuminuria is common among German persons with known type 2 diabetes. Despite evidence-based guidelines, only a small proportion of type 2 diabetic persons achieved the recommended levels of glycemic control and control of cardiovascular risk factors.
Literature
2.
go back to reference Deckert T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T: Microalbuminuria: implications for micro- and macro-vascular disease. Diabetes Care. 1992, 15: 1181-1191. 10.2337/diacare.15.9.1181.CrossRefPubMed Deckert T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T: Microalbuminuria: implications for micro- and macro-vascular disease. Diabetes Care. 1992, 15: 1181-1191. 10.2337/diacare.15.9.1181.CrossRefPubMed
3.
go back to reference Ritz E: Nephropathy in type 2 diabetes. J Intern Med. 1999, 245: 111-126. 10.1046/j.1365-2796.1999.00411.x.CrossRefPubMed Ritz E: Nephropathy in type 2 diabetes. J Intern Med. 1999, 245: 111-126. 10.1046/j.1365-2796.1999.00411.x.CrossRefPubMed
4.
go back to reference Raine AE: Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia. 1993, 36: 1099-1104. 10.1007/BF02374505.CrossRefPubMed Raine AE: Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia. 1993, 36: 1099-1104. 10.1007/BF02374505.CrossRefPubMed
5.
go back to reference Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, Nielsen B, Larsen S: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 1992, 41: 758-762. 10.1038/ki.1992.118.CrossRefPubMed Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, Nielsen B, Larsen S: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 1992, 41: 758-762. 10.1038/ki.1992.118.CrossRefPubMed
6.
go back to reference Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003, 63 (1): 225-232. 10.1046/j.1523-1755.2003.00712.x.CrossRefPubMed Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003, 63 (1): 225-232. 10.1046/j.1523-1755.2003.00712.x.CrossRefPubMed
8.
go back to reference Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH: Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004, 66: 1596-1605. 10.1111/j.1523-1755.2004.00925.x.CrossRefPubMed Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH: Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004, 66: 1596-1605. 10.1111/j.1523-1755.2004.00925.x.CrossRefPubMed
9.
go back to reference Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD: Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int. 2004, 66: 1131-1138. 10.1111/j.1523-1755.2004.00863.x.CrossRefPubMed Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD: Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int. 2004, 66: 1131-1138. 10.1111/j.1523-1755.2004.00863.x.CrossRefPubMed
10.
go back to reference Kuch B, von Scheidt W, Peter W, Döring A, Piehlmeier W, Landgraf R, Meisinger C: Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg Diabetes Family Study. Diabetes Care. 2007, 30: 946-952. 10.2337/dc06-2123.CrossRefPubMed Kuch B, von Scheidt W, Peter W, Döring A, Piehlmeier W, Landgraf R, Meisinger C: Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg Diabetes Family Study. Diabetes Care. 2007, 30: 946-952. 10.2337/dc06-2123.CrossRefPubMed
11.
go back to reference Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139: 137-147.CrossRefPubMed Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139: 137-147.CrossRefPubMed
12.
go back to reference European Society of Hypertension-European Society of Cardiology Guidelines Committee: Guidelines for the management of arterial hypertension. J Hypertens. 2003, 21: 1011-1053. 10.1097/00004872-200306000-00001.CrossRef European Society of Hypertension-European Society of Cardiology Guidelines Committee: Guidelines for the management of arterial hypertension. J Hypertens. 2003, 21: 1011-1053. 10.1097/00004872-200306000-00001.CrossRef
13.
go back to reference American Diabetes Association: Standards of medical care in diabetes. Diabetes Care. 2005, 28: S4-S36. 10.2337/diacare.28.suppl_1.S4.CrossRef American Diabetes Association: Standards of medical care in diabetes. Diabetes Care. 2005, 28: S4-S36. 10.2337/diacare.28.suppl_1.S4.CrossRef
14.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ: Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003, 42: 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ: Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003, 42: 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.CrossRefPubMed
15.
go back to reference Herman WH, Aubert RE, Engelgau MM, Thompson TJ, Ali MA, Sous ES, Hegazy M, Badran A, Kenny SJ, Gunter EW, Malarcher AM, Brechner RJ, Wetterhall SF, DeStefano F, Smith PJ, Habib M, abd el Shakour S, Ibrahim AS, el Behairy EM: Diabetes mellitus in Egypt: Glycaemic control of microvascular and neuropathic complications. Diabet Med. 1998, 15: 1045-1051. 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L.CrossRefPubMed Herman WH, Aubert RE, Engelgau MM, Thompson TJ, Ali MA, Sous ES, Hegazy M, Badran A, Kenny SJ, Gunter EW, Malarcher AM, Brechner RJ, Wetterhall SF, DeStefano F, Smith PJ, Habib M, abd el Shakour S, Ibrahim AS, el Behairy EM: Diabetes mellitus in Egypt: Glycaemic control of microvascular and neuropathic complications. Diabet Med. 1998, 15: 1045-1051. 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L.CrossRefPubMed
16.
go back to reference Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, Deambrogio P, Pagano G: Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care. 1996, 19: 43-47. 10.2337/diacare.19.1.43.CrossRefPubMed Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, Deambrogio P, Pagano G: Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care. 1996, 19: 43-47. 10.2337/diacare.19.1.43.CrossRefPubMed
17.
go back to reference Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int. 2002, 61: 2165-2175. 10.1046/j.1523-1755.2002.00356.x.CrossRefPubMed Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int. 2002, 61: 2165-2175. 10.1046/j.1523-1755.2002.00356.x.CrossRefPubMed
18.
go back to reference Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, Welborn TA, Atkins RC: Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis. 2004, 44: 792-798. 10.1016/S0272-6386(04)01079-0.CrossRefPubMed Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, Welborn TA, Atkins RC: Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis. 2004, 44: 792-798. 10.1016/S0272-6386(04)01079-0.CrossRefPubMed
19.
go back to reference Standl E, Stiegler H: Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area. Diabetologia. 1993, 36 (10): 1017-1020. 10.1007/BF02374493.CrossRefPubMed Standl E, Stiegler H: Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area. Diabetologia. 1993, 36 (10): 1017-1020. 10.1007/BF02374493.CrossRefPubMed
20.
go back to reference Piehlmeier W, Renner R, Schramm W, Kimmerling T, Garbe S, Proetzsch R, Fahn J, Piwernetz K, Landgraf R: Screening of diabetic patients for microalbuminuria in primary care – The PROSIT-Project. Proteinuria Screening and intervention. Exp Clin Endocrinol Diabetes. 1999, 107 (4): 244-251.CrossRefPubMed Piehlmeier W, Renner R, Schramm W, Kimmerling T, Garbe S, Proetzsch R, Fahn J, Piwernetz K, Landgraf R: Screening of diabetic patients for microalbuminuria in primary care – The PROSIT-Project. Proteinuria Screening and intervention. Exp Clin Endocrinol Diabetes. 1999, 107 (4): 244-251.CrossRefPubMed
21.
go back to reference Varghese A, Deepa R, Rema M, Mohan V: Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J. 2001, 77: 399-402. 10.1136/pmj.77.908.399.CrossRefPubMedPubMedCentral Varghese A, Deepa R, Rema M, Mohan V: Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J. 2001, 77: 399-402. 10.1136/pmj.77.908.399.CrossRefPubMedPubMedCentral
22.
go back to reference Gambaro G, Bax G, Fusaro M, Normanno M, Manani SM, Zanella M, Dangelo A, Fedele D, Favaro S: Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab. 2001, 14: 337-342.PubMed Gambaro G, Bax G, Fusaro M, Normanno M, Manani SM, Zanella M, Dangelo A, Fedele D, Favaro S: Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab. 2001, 14: 337-342.PubMed
23.
go back to reference Chan JC, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS: Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgrad Med J. 1993, 69: 204-210.CrossRefPubMedPubMedCentral Chan JC, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS: Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgrad Med J. 1993, 69: 204-210.CrossRefPubMedPubMedCentral
24.
go back to reference Liebl A, Mata M, Eschwège E: Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia. 2002, 45: S23-S28. 10.1007/s00125-002-0874-x.CrossRefPubMed Liebl A, Mata M, Eschwège E: Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia. 2002, 45: S23-S28. 10.1007/s00125-002-0874-x.CrossRefPubMed
25.
go back to reference UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes : UKPDS 38. BMJ. 1998, 317: 703-713.CrossRefPubMedCentral UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes : UKPDS 38. BMJ. 1998, 317: 703-713.CrossRefPubMedCentral
26.
go back to reference Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998, 351: 1755-1762. 10.1016/S0140-6736(98)04311-6.CrossRefPubMed Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998, 351: 1755-1762. 10.1016/S0140-6736(98)04311-6.CrossRefPubMed
27.
go back to reference Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997, 20: 614-620. 10.2337/diacare.20.4.614.CrossRefPubMed Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997, 20: 614-620. 10.2337/diacare.20.4.614.CrossRefPubMed
28.
go back to reference Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003, 348 (5): 383-393. 10.1056/NEJMoa021778.CrossRefPubMed Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003, 348 (5): 383-393. 10.1056/NEJMoa021778.CrossRefPubMed
29.
go back to reference Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004, 291: 335-342. 10.1001/jama.291.3.335.CrossRefPubMed Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004, 291: 335-342. 10.1001/jama.291.3.335.CrossRefPubMed
30.
go back to reference Charpentier G, Genès N, Vaur L, Amar J, Clerson P, Cambou JP, Gueret P, ESPOIR Diabetes Study Investigators: Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab. 2003, 29: 152-158. 10.1016/S1262-3636(07)70022-8.CrossRefPubMed Charpentier G, Genès N, Vaur L, Amar J, Clerson P, Cambou JP, Gueret P, ESPOIR Diabetes Study Investigators: Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab. 2003, 29: 152-158. 10.1016/S1262-3636(07)70022-8.CrossRefPubMed
31.
go back to reference Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM: Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care. 2004, 27: 694-698. 10.2337/diacare.27.3.694.CrossRefPubMed Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM: Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care. 2004, 27: 694-698. 10.2337/diacare.27.3.694.CrossRefPubMed
Metadata
Title
Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study
Authors
Christa Meisinger
Margit Heier
Rüdiger Landgraf
Michael Happich
H-Erich Wichmann
Wolfgang Piehlmeier
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2008
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-8-226

Other articles of this Issue 1/2008

BMC Health Services Research 1/2008 Go to the issue

Correspondence

The value of health